Clinical trial
Prophylaxis of the Graft-Versus-Host-Disease in Patients After Allogeneic Stem Cell Transplantation With a Combination of Tacrolimus and Everolimus
NCT00117702 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylaxis of the Graft-Versus-Host-Disease in Patients After Allogeneic Stem Cell Transplantation With a Combination of Tacrolimus and Everolimus
- Lead sponsor
- Technische Universität Dresden
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- October 31, 2005
- Completion date
- May 31, 2008
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.